Webcasts

Webinar Date/Time: Tue, Mar 4, 2025 11:00 AM EST

Webinar Date/Time: Wed, Feb 26, 2025 11:00 AM EST

Webinar Date/Time: Thu, Dec 12, 2024 11:00 AM EST

Webinar Date/Time: Wed, Dec 4, 2024 11:00 AM EST

Webinar Date/Time: Thu, Nov 14, 2024 11:00 AM EST

Webinar Date/Time: Thu, Nov 7, 2024 11:00 AM EDT

Webinar Date/Time: Thu, Oct 31, 2024 11:00 AM EDT

Webinar Date/Time: Wed, Oct 16, 2024 11:00 AM EDT

Webinar Date/Time: Thurs, September 19, 2024 Session 1: 9:00am EDT | 1:00pm GMT | 2:00pm CET Session 2: 1:00pm EDT| 5:00pm GMT | 6:00 am CET

Webinar Date/Time: Wed, Jul 24, 2024 12:00 PM EDT

Webinar Date/Time: Thu, Jun 20, 2024 10:00 AM EDT

Webinar Date/Time: Thu, Jun 13, 2024 11:00 AM EDT

Webinar Date/Time: Thu, Thu, Apr 18, 2024 11:00 AM EDT

Webinar Date/Time: Wed, May 8, 2024 11:00 AM EDT

Webinar Date/Time: Wed, Mar 20, 2024 11:00 AM EDT

Webinar Date/Time: Thu, Feb 8, 2024 11:00 AM EST

Webinar Date/Time: Tue, Dec 5, 2023 11:00 AM EST

Webinar Date/Time: Wed, Dec 6, 2023 11:00 AM EST

Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST

Webinar Date/Time: Thursday, September 28th, 2023 10:00 AM EDT

Webinar Date/Time: Thu, Jul 27, 2023 11:00 AM EDT

Webinar Date/Time: Tue, May 2, 2023 11:00 AM EDT

Webinar Date/Time: Thu, Apr 27, 2023 10:00 AM EDT

Webinar Date/Time: Tue, Apr 11, 2023 11:00 AM EDT

Webinar Date/Time: Tue, Jan 24, 2023 11:00 AM EST

Webinar Date/Time: Thu, Dec 1, 2022 11:00 AM EST

Monday, October 17, 2022 at 11am EDT | 4pm BST | 5pm CEST Why would a CDMO to leverage fixed-bed bioreactor technology to develop and produce GMP lentiviral vectors? Join us for a discussion on increasing quality and decreasing time and cost to accelerate time to clinic and market for lentiviral products with technology.

Thursday, October 13, 2022, at 11am EDT Cell culture media (CCM) and feed strategy optimization can be a time time-consuming and complex process. Presented in this webcast are data-driven and accelerated CCM optimization in the Ambr15, leveraging an automated at-line capillary electrophoresis—the REBEL, a mass cell culture spectrometry analyzer- to speed up and optimize CCM and feed strategy optimization.

Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.

Wednesday, April 13, 2022 at 2pm EST | 1pm CST | 11am PST Selecting raw materials for developing and manufacturing is not a trivial decision. Join us and learn how to avoid mistakes in raw material selection that can delay or prevent a promising mRNA therapeutic or vaccine from reaching the market..